(6 bill codes)

Diabetes & Four Devices

The DM Quatro are four (4) individual FDA Cleared tools that assess the autonomic nervous system (ANS), diabetic retinopathy (DR), diabetic peripheral neuropathy (DPN), and peripheral arterial disease (PAD). 

Screening for Diabetes Complications

The DM Quatro Provides ANS, DR, DPN, and PAD All-in-One Visit!

The DM Quatro are medical devices with the following features: 

Diabetic Retinopathy Exam Diabetic Retinopathy is an eye condition that can cause vision loss and blindness in people and should not be confused with an ophthalmoscope eye exam. 50% of diabetic patients lack documentation of a retinal eye exam which is the most difficult HEDIS measure to meet. Therefore, insurance companies are grateful for assistance to close the gap in care.

Diabetic Neuropathy Device™ is the First FDA Cleared Multi-Objective Innovation that Identifies, and Measures Peripheral Neuropathy. 

Autonomic Nervous System (ANS) device is FDA Cleared and Measures Arterial Stiffness, Vascularization, and Endothelial Function.

TruPAD™ is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow. 

Features of the tests:

Major Causes

Get Tested If

Competitive Advantages

Simply Better